Search results
EMA CHMP recommends AstraZeneca’s Tagrisso for lung cancer
Pharmaceutical Technology via Yahoo Finance· 1 day agoThe Tagrisso regimen is intended for treating patients with locally advanced or metastatic epidermal...
Hypoxemia due to sleep apnea is associated with risk of lung cancer reoccurrence
Medical Xpress· 18 hours agoResults show that a 4% oxygen desaturation index of more than 15 and time spent in desaturation...
Cancer patients often do better with less intensive treatment, research shows
NBC NEWS· 2 days agoScaling back treatment for three kinds of cancer can make life easier for patients without...
Weight loss jabs have 'enormous potential' to cut risk of obesity-related cancer
Daily Express· 17 hours agoWeight loss jabs such as Ozempic have “enormous potential” as a new weapon in the fight against ...
Pfizer Study Shows Lorbrena Reduces Chances of Lung Cancer Getting Worse
Morningstar· 5 days agoPfizer said a majority of patients in a study of its lung cancer treatment Lorbrena remained alive after five years without the disease ...
Phase III trial shows lorlatinib highly effective against ALK-positive non–small cell lung cancer
Medical Xpress· 18 hours agoA large team of medical researchers and doctors has found via phase III clinical trial that the ALK inhibitor lorlatinib is highly effective for treating non–small cell lung
What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck
Forbes· 1 day agoCancer vaccines are finally showing promise as Moderna and Merck touted promising data on an...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 2 hours agoPierre Fabre Laboratories Announce IND Filing for PFL-002/VERT-002, a Potential Treatment for Patients with Solid Tumors, Including Non-Small Cell Lung Cancer< ...
Rich people have 'greater cancer risk' than poor, study finds
Yahoo Life UK· 2 days agoResearchers from Finland looked at the influence of socio-economic status (SES) on the...had higher...
Affimed (AFMD) Soars on Upbeat Follow-Up Data From NSCLC Study
Zacks· 1 day agoThe phase I/IIa AFM24-102 study is evaluating AFM24 in combination with Roche’s (RHHBY Quick...